#
Name of Investigator(s)
Research Title
Publisher and Date of Publication
1
N. Maksud, S. Bera, M.J. Naim, O Alam
Dapagliflozin: A New Hope for the Therapeutic Treatment of Type 2 Diabetes Mellitus
Eur. J. Med. Chem Reports.
May 2024
2
M.J. Naim
A review on mushrooms as a versatile therapeutic agent with emphasis on its bioactive constituents for anticancer and antioxidant potential.
Exploration Med.
May 2024
3
M.J. Naim
A Review of Dipeptidyl Peptidase-4 (DPP-4) and its potential synthetic derivatives in the management of Diabetes Mellitus.
J. Angiotherapy
Jan 2024
4
Z. Saleem, A.A. Khan, S.A. Naaz, M.J. Naim
Polycystic Ovarian Syndrome: An Overview with Special Consideration to Its Oral and Pediatric Clinical Manifestations.
J. Angiotherapy
Jan 2024
5
A. Ahamad, J. Ahamad, M.J. Naim
Current Perspective on Pesticides: Their Classification, Behaviour, Potential Use and Toxic Effects.
J. Angiotherapy
Dec 2023
6
M. J. Naim, J. Ahamad
Piperine: A Mini Review on its Pharmacological Profile and Synthetic Derivatives
Eurasian J. Sci. Eng. Jan 2023
7
A. Ahamad, K. J. Naquvi, M. J. Naim, J. Ahamad, S.H. Ansari, S. Ahmad
Integrated Network Pharmacology and In-Silico Molecular Docking Studies to Unveil Mechanism of Action of Polyphenolic Compounds of Psidium Guajava for The Management of Thrombocytopenia
Eurasian J. Sci. Eng. Jan 2023
8
M. J. Naim, A. Ahamad, E.T. Anwer, A. S. Salahuddin
Curcumin: A Mini Review on its Synthetic Derivatives
Eurasian J. Sci. Eng. Jan 2023
9
J. Ahamad, A. Y. Omer, D. A. Majid, T. M. Khidr, S.Y. Jameel, M. J. Naim, E.T. Anwer, S. Utirapathy
Chemical Characterization and Detection of Adulteration in Essential Oil of Lavandula Angustifolia Linn. by ATR-FTIR
Eurasian J. Sci. Eng. Dec 2022
10
M.J. Alam, O. Alam, M. J. Naim, F. Nawaz, A. Manaithiya, M. Imran, H.K. Thabet, S. Alshehri, M.M. Ghonei, P. Alam and F. Shakeel
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics.
Molecules (Impact factor: 4.927)
Dec 2022
11
M.N. Javed, F.H. Pottoo, M.J. Naim, P.A. Chawla
Recent Advancements in CNS Acting Drugs: A Step Towards End of Illness
CNS & Neurological Disorders-Drug Targets (Impact factor: 2.824)
Dec 2022
12
M.S. Abd Wahab, N.N. Abd Hamid, A.O. 
Yassen, M.J. Naim, J. Ahamad, N.W. Zulkifli, F.F. Ismail, M.H. Zulkifli, K.W. Goh and L.C. Ming
How Internet Websites Portray Herbal Vitality Products Containing Eurycoma longifolia Jack: An Evaluation of the Quality and Risks of Online Information
Int. J. Environ. Res. Public Health (Impact factor: 3.39)
Sep 2022
13
R. Pal, K. Singh, J. Paul, S.A. Khan, M.J. Naim, M.J. Akhtar
Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant agents
Curr. Neuropharmacol.
(Impact factor: 7.363)
Aug 2022
14
A. Manaithiya, O. Alam, S. Mittal, M.J. Naim, M.I., Ahmed, S. Alshrari, A.A Sheikh, I.A. Khan
An Updated and Focused Review on Heterocyclic Inhibitors for SARS-CoV and SARS-CoV-2 3CLpro.
Mini Rev. Med. Chem. (Impact factor: 3.862)
May 2022
15
M.J. Alam, O. Alam, A. Perwez, M.A. Rizvi, M.J. Naim, V.G.M. Naidu, M. Imran, M.M. Ghoneim, S. Alshehri, F. Shakeel
Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors
Pharmaceuticals (Impact factor: 4.94)
Feb 2022
16
J. Sankaraiah, N. Sharma, M.J. Naim
Formulation and Development of Fixed-Dose Combination of Bi-Layer Tablets of Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 600 Mg/300 Mg/300 Mg
Int. J. App. Pharm, (Impact factor: 0.824) Jan 2022
17
P.S. Maurya, M.J. Naim, R.K. Singh, J. Bashar
Tulsi: A Miracle herb used in the Treatment of Many Illnesses: A Review
Curr. Res. Pharm. Sci. (Impact factor: 0.81)
Dec 2021
18
S. Rathore, A. Ram, D. Lall, B. Agrawal, P. Soni, M.J. Naim
Development and evaluation of sunscreen cream containing benzophenone-3 microspheres for enhancing sunscreen activity
Res. J. Pharm. Tech. (Impact factor: 1.203)
Nov 2021
19
P.S. Maurya, M.J. Naim, N. Sharma
Simultaneous Estimation of Lornoxicam and Paracetamol in Combined Tablet Dosage Form Using Reverse Phase High-Performance Liquid Chromatography Method
Curr. Res.  Pharma. Sci. Sep 2021
20
A. Manaithiya, O. Alam*, V. Sharma, M.J. Naim, S. Mittal, F. Azam, A. Husain, A.A. Sheikh, M. Imran and I.A. Khan
Current status of novel pyridine fused derivatives as anticancer agents: An insight into future perspectives and structure activity relationship (SAR)
Accepted
Curr. Top. Med. Chem.
(Impact factor: 3.295)
Aug 2021
21
I.                Mittal, M.J. Naim, A. Singh, S. Mandal.
A Review on Holy Improving Plant Nyctanthes Arbor-Tristis Linn. (Night Jasmine) With Monster Therapeutic Possibilities
Accepted
Int. J. Modern
Pharm. Res.
June 2021
22
A. Manaithiya, O. Alam, V. Sharma a, M.J. Naim, S. Mittal,
I.A. Khan
GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus.
Bioorg. Chem.
(Impact factor: 5.275)
May 2021
23
D. lall, M.J. Naim, S. Rathore
Development and evaluation of sunscreen cream containing benzophenone-3 microspheres for enhancing sunscreen activity.
Accepted
Res. J. Pharm. Tech.
(March 2021)
24
M. Jha, O. Alam,
M.J. Naim, F. Nawaz, V. Sharma, P. Bhatia, A.A. Sheikh.
Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and docking.
Eur. J. Pharm. Sci.
 (Impact Factor: 4.384)
July 2020
25
F. Nawaz, O. Alam, A. Perwez, M.A. Rizvi, M.J. Naim, N. Siddiqui, J.U. Firdaus, S. Rahman, M. Jha, A.A. Sheikh.
Design, synthesis, molecular docking and anticancer evaluation of pyrazole linked pyrazoline derivatives with carbothioamide tail as EGFR kinase inhibitors.
Anticancer Agents Med. Chem.
Accepted
(Impact Factor: 2.505) June 2020
26
K. Uddin, M.J. Naim, A. Kumar.
Biological potential of Benzoxazole derivatives: An updated review.
Asian J. Pharm. and Clinical Res.,
May 2020
27
F.H. Pottoo, S. Sharma, M.N. Javed, M.A. Barkat, Harshita, M.S. Alam, M.J. Naim, O. Alam, M.A. Ansari, G.E. Barreto, G.M. Ashraf
Lipid-based nano-formulations in the treatment of neurological disorders
Drug Metab. Rev. (Impact Factor: 4.53)
February 2020
28
F. Nawaz, O. Alam, A. Perwez, M.A. Rizvi, M.J. Naim, N. Siddiqui, F.H. Pottoo, M. Jha
3’-(4-(benzyloxy) phenyl)-1’-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1’H,2H-[3,4’-bipyrazole]-2-carboxamide as a EGFR kinase inhibitors: Synthesis, anticancer evaluation and molecular docking studies
Arch der pharm
(Impact Factor: 3.751)
January 2020
29
V. Sharma, P. Bhatia, O. Alam, M.J. Naim, F. Nawaz, A.A. Sheikh, M. Jha
Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008–2019).
Bioorg. Chem.
(Impact factor: 5.275)
May 2019
30
B. Nusrat, N. Siddiqui, M. Sahu, M.J. Naim, M.S. Yar, R. Ali, O. Alam.
Anticonvulsant evaluation of 2-pyrazolines carrying naphthyl moiety: An insight into synthesis and molecular docking study.
Braz. J. Pharm. Sci. (Impact Factor: 0.814 ),
May 2019
31
J.U. Firdaus, A. Habib, N. Siddiqui, O. Alam, M.J. Naim, S. Partap, M. Sahu.
Design, synthesis and molecular docking study of benzothiazolotriazine derivatives for anticonvulsant potential.
Arch der pharm
(Impact Factor: 3.751),
November 2018
32
P. Goel, O. Alam, M.J. Naim, F. Nawaz, M. Iqbal, M.I. Alam
Recent advancement of piperidine moiety in treatment of cancer- A review.
Eur. J. Med. Chem. (Impact Factor: 6.514), August 2018
33
S. Ahmad, O. Alam, M.J. Naim, M. Shaquiquzzaman, M.M. Alam, M. Iqbal
Pyrrole: An insight into recent pharmacological advances with structure activity relationship.
Eur. J. Med. Chem. (Impact Factor: 6.514),
August 2018
34
M.J. Naim, O. Alam, M.J. Alam, M.S. Zaman, M.M. Alam and V.G.M. Naidu
Synthesis, Docking, In-vitro and In-vivo antidiabetic activity of pyrazole based 2,4-thiazolidinedione derivatives as PPARγ modulator.
Arch der Pharm. (Impact Factor: 3.751), February 2018
35
M.J. Naim, O. Alam, M.J. Alam, M.Q. Hassan, N. Siddiqui, V.G.M. Naidu, M.I. Alam
Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
Bioorg. Chem.
(Impact Factor: 5.275),
November 2017
36
A. Barkat, Harshita, S. Beg, M.J. Naim, F.H. Pottoo, S.P. Singh, F.J. Ahmad
Current Progress in Synthesis, Characterization and Applications of Silver Nanoparticles: Precepts and Prospects.
Recent Pat. Antiinfect. Drug Discov. (Impact Factor: 1.1),
September 2017
37
M. Sahu, N. Siddiqui, M.J. Naim, O. Alam, M.S. Yar, V. Sharma, S. Wakode
Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models
Arch. Pharm. (Impact Factor: 3.751),
July 2017
38
M.J. Naim, M.J. Alam, F. Nawaz, V.G.M. Naidu, S. Aaghaz, M. Sahu, N. Siddiqui, O. Alam
Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives.
Bioorg. Chem. (Impact Factor: 5.275), May 2017
39
N. Shrivastava, M.J. Naim, M.J. Alam, F. Nawaz, S. Ahmed, O. Alam
Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure–Activity Relationship.
Arch. Pharm. (Impact Factor: 3.751), May 2017
40
M.J. Naim, M.J. Alam, S. Ahmad, F. Nawaz, N. Shrivastava, M. Sahu, O. Alam
Therapeutic journey of 2, 4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship.
Eur. J. Med. Chem. (Impact Factor: 6.514),
March 2017
41
N. Siddiqui, M.S. Alam, M. Sahu, M.J. Naim, M.S. Yar, O. Alam
Design, synthesis, anticonvulsant evaluation and docking study of 2-[(6-substituted benzo [d] thiazol-2-ylcarbamoyl) methyl]-1-(4-substituted phenyl) isothioureas.
Bioorg. Chem. (Impact Factor: 5.275), February 2017
42
M.J. Alam, O. Alam, S.A. Khan, M.J. Naim, M. Islamuddin, G.S. Deora
Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues.
Drug Des. Dev. Ther. (Impact Factor: 3.216), October 2016
43
M.J. Naim, O. Alam, F. Nawaz, M.J. Alam, P. Alam
Current status of pyrazole and its biological activities.
J. Pharm. Bioallied Sci. (Impact Factor: 1.48), March 2016
44
M.J. Naim, O. Alam, M.J. Alam, F. Bano, P. Alam, N. Shrivastava
Recent review on indole: a privileged structure scaffold.
Int. J. Pharm. Sci. Res.
February 2016
45
J. Uthuppan, O. Alam, M.J. Naim, F. Nawaz, M.J. Alam, A.K. Panda, M.A. Alam, V. Devaraji
Design, synthesis, and molecular docking of pyrazole carboxamide derivatives bearing benzene sulfonamide tail as potential anticancer agents.
J. Pharm. Bioallied Sci. (Impact Factor: 1.48),
January 2016
46
M.J. Alam, O. Alam, R. Ali, M.J. Naim, S.A. Khan
Synthesis and anti-inflammatory activity of some new thiadiazole linked pyrazole benzene sulphonamides as cyclooxygenase inhibitors.
Orient. J. Chem. (Impact Factor: 0.68), December 2015
47
M.J. Naim, O. Alam, M.J. Alam, P. Alam, N. Shrivastava
A review on pharmacological profile of Morpholine derivatives.
Int. J. Pharm. December 2015
48
M.J. Alam, O. Alam, N. Shrivastava, M.J. Naim, P. Alam
Pyrimidine candidate as promising scaffold and their biological evaluation.
Int. J. Pharmacol. December 2015
49
M.J. Alam, O. Alam, P. Alam, M.J. Naim
A review on pyrazole chemical entity and biological activity
Int. J. Pharm. Sci. Res. December 2015
50
M.J. Alam, O. Alam, M.J. Naim, P. Alam
A review: Recent investigations on Quinazoline Scaffold.
Int. J. Adv. Res. December 2015
51
M.J. Naim, O. Alam, F. Nawaz
Recent target-based discovery of anti-diabetic agents.
Int. J. Pharm. Sci. Res. May 2015